CHLORASEPTIC MAX
NDC 67172-114, Menthol and Benzocaine, lozenge, from Prestige Brands Holdings, Inc..
- Product NDC
- 67172-114
- Status
- Listed
- Labeler
- Prestige Brands Holdings, Inc.
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M022
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67172-114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MENTHOL10 mg/1
- BENZOCAINE15 mg/1
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67172-114-61 | 67172011461 | 1 BLISTER PACK in 1 CARTON (67172-114-61) / 15 LOZENGE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 67172-114 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67172-114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67172-114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.